Τόμος 20 (2006) – Τεύχος 2 – Άρθρο 5 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 20 (2006) – Issue 2 – Article 5 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Department of Psychiatry, Medical School, University of Patras

2. Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras

3. Department of History of Medicine and Medicinal Deontology, Medical School, University of Crete, Greece

pharmakonpress[at]pharmakonpress[.]gr

1. Altshuler L.L., Hendrick V., Cohen L.S: Course of mood and anxiety disorders during pregnancy and the postpartum period. J. Clin. Psychiatry 59: 29-33
2. Altshuler L.L., Cohen L.S., Moline M.L., Kahn D.A., Carpenter D., Docherty J.P.: Treatment of depression in women: a summary of the expert consensus guidelines. J. Psychiatr. Pract. 7: 185-208 (2001)
3. Alves W.A., Macciocchi S.N.: Ethical Considerations in Clinical Neuroscience. Curr. Conc. Neurocl. Trials 27: 1903-1909 (1996)
4. American College of Neuropsychopharmacology: A statement of principles of ethical conduct for neuropsychopharmacologic research in human subjects. In: Directory of Members 2001. ACNP, Nashville, pp 225-238, 2001
5. Appelbaum P.S., Grisso T., Frank E., O’Donnell S., Kupfer D.J.: Competence of depressed patients for consent to research. Am. J. Psychiatry 156: 1380-1384 (1999)
6. Auerswald K.B.,Charpentier P.A., Inouye S.K.: The informed consent process in older patients who developed delirium: A clinical epidemiologic study. Am. J. Med. 5: 410-418 (1997) Avins A.L.: Can unequal be more fair? Ethics, subject allocation, and randomized clinical trials. J. Med. Ethics 24: 401-408 (1998)
7. Bonnie R.J.: Research with cognitively impaired subjects: unfinished business in the regulation of human research. Arch. Gen. Psychiatry 54: 105-111 (1997)
8. Bodenheimer T.: Uneasy alliance: clinical investigators and the pharmaceutical industry. Health Pol. Rep. 342: 1539-1544 (2000)
9. Candilis P.J., Wesley R.W., Wichman A.: A survey of  researchers using a consent policy for cognitively impaired human research subjects. /RB 15: 1-4 (1993)
10. Charney D.S., Nemeroff C.B., Lewis L., Laden S.K., Gorman J.M., Laska E.M., Borenstein M., Bowden C.L., Caplan A., Emslie G.J., Evans D.L., Geller B., Grabowski L.E., Herson J., Kalin N.H., Keck P.E.,Jr, Kirsch I., Krishnan K.R., Kupfer D.J., Makuch R.W., Miller F.G., Pardes H., Post R., Reynolds M.M., Roberts L., Rosenbaum J.F., Rosenstein D.L., Rubinow D.R., Rush A.J., Ryan N.D., Sachs G.S., Schatzberg A.F., Solomon S.: National  Depressive and  Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch. Gen. Psychiatry 59: 262-270 (2002)
11. Cherniack E.P.: Informed consent for medical research by the elderly. Exp. Aging Res. 28: 183-198 (2002)
12. Carpenter W.T., Gold J.M., Lahti A.C., Queern C.A., Conley R.R., Bartko J.J., Kovnick J., Appelbaum P.S.: Decisional capacity for informed consent in schizophrenia research. Arch. Gen. Psychiatry 57: 533-538 (2000)
13. Carpenter W.T., Gold J.M., Lahti A.C., Queern C.A., Conley R.R., Bartko McCarthy A.M., Richman L.C., Hoffman R.P., Rubenstein L.: Psychological screening of children for participation in nontherapeutic invasive research. Arch. Pediatr. Adolesc. 155: 1197-1203 (2001)
14. DeGrazia D.: Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia, Schizophrenia Res. 1: 77-86 (2001)
15. Department of Health and Human Services: Protection of human subjects. Basic HHS policy for protection of human research subjects. Code of Federal Regulations, Title 45, Public Welfare: Part 46, Subpart A: 46.101-46.124, Revised June 18, 1991, Effective August 19, 1991. Office of the Federal Register, National Archives and Records Administration, Washington, DC, October 1, 1994 (45 CFR Subtitle A), pp 116-127
16. Department of Health and Human Services: Protection of human subjects. Subpart D: Additional protections for children involved as subjects in research. Code of Federal Regulations, Title 45, Public Welfare: Part 46, Subpart D: 46.401-46.409, Revised June 18, 1991, Effective August 19, 1991. Office of the Federal Register, National Archives and Records Admini- stration, Washington, DC, October 1, 1994 (45 CFR Subtitle A), pp 132-135
17. Emanuel E.J., Miller F.G.: The ethics of placebo-controlledtrials – a middle ground. N. Engl. J. Med. 345: 915-919 (2001) Emanuel E.J., Wendler D., Grady C.: What makes clinical research ethical? JAMA 283: 2701-2711 (2000)
18. Food and Drug Administration: 21CFR Parts 5- and 56. Additional safeguards for children in clinical investigations of FDA- regulated products. Federal Register 65: 20589-20600, 2001, http://www.fda.gov/OHRMS/DOCKETS/98fr/042401a.pdf Kantor J.E.: Ethical issues in psychiatric research and training. In: (Oldham J.M., Riba M.B., eds) Annual Review of Psychiatry. Vol 13, pp 33-342, American Psychiatric Press, Wash- ington D.C., 1994
19. Kaplan S., Brownlee S.: Dying for a cure. US News and World Report, October 11, 1999
20. Katz J.: Human sacrifice and human experimentation: reflections at Nuremberg. Yale Law School Occasional Papers 2: 16-17 (1997)
21. Kovnick J., Appelbaum P.S.: Decisional capacity for informed consent in schizophrenia research. Arch. Gen. Psychiatry 57: 533-538 (2000)
22. Llewellyn A.M., Stowe Z.N., Nemeroff C.B.: Depression during pregnancy and the puerperium. J. Clin. Psychiatry 58: 26-32 (1997)
23. Masand P.D., Gupta S.: SSRIs: an update. Harv. Rev. Psychiatry 7: 69-84 (1999)
24. Munir K., Earls F.: Ethical principles governing research in child and adolescent psychiatry. J. Am. Acad. Child Adolesc. Psychiatry (1992)
25. National Bioethics Advisory Commission: Ethical and policy issues in research involving human participants, 2001. Bethesda, Md. National Institute of Health, 2002: Bioethics resources on the Web [on-line]. Available:   http://www.nih.gov/sigs/bioethics/IRB.html
26. National Bioethics Advisory Commission (NBAC): Report on research involving persons with mental disorders that may affect decision making capacity. Vol. I, Washington, DC, 1998
27. National Bioethics Advisory Commission (NBAC): Report on research involving persons with mental disorders that may affect decision making capacity. Vol. II, Washington, DC, 1999 National Institutes of Health: Research on ethical issues in human subjects. PA-02-103, NIH Guide, 1 May 2002, http:// grants2.nih.gov/grants/guide/pa-files/PA-02-103.html Office for Human Research Protection: IRB guidebook (online), 2002.:http://ohrp.osophs.dhhs.gov/irb/irb_guidebook.Htm
28. Palmer B.W., Nayak G.V., Dunn L.B., Appelbaum P.S., Jeste D.V.: Treatment-related decision-making capacity in middle- aged and older patients with psychosis: a preliminary study using the MacCAT-T and HCAT. Am. J. Geriatr. Psychiatry 10: 207-211 (2002)
29. Paul M., Foreman D.M., Kent L.: Outpatient clinic attendance: consent from children and young people-ethical aspects and practical considerations. Clin. Child.  Psychol. Psychiatry 5: 203-211 (2000)
30. Quitkin F.M.: Placebos, drug effects, and study design: a clinician’s guide. Am. J. Psychiatry 156: 829-836 (1999)
31. Riddle M.A., Kastelic E.A., Frosch E.: Pediatric psychopharmacology. J. Child Psychol. Psychiatry 42: 73-90 (2001)
32. Roberts L.W.: Ethical dimensions of psychiatric research: a constructive, criterion-based approach to protocol preparation. The research protocol ethics assessment tool (RePEAT). Biol. Psychiatry 46: 1106-1119 (1999)
33. Roberts L.W., Warner T.D., Brody J.L.: Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am. J. Psychiatry 157: 67-74 (2000)
34. Roberts L.W., Geppert C., Brody J.L.: A framework for considering the ethical aspects of psychiatric research  protocols. Com. Psychiatry 42: 351-363 (2001)
35. Roberts L.W., Lauriello J., Geppert C., Keith S.J.: Placebos and paradoxes in psychiatric research: an ethics perspective. Biol. Psychiatry 49: 887-893 (2001)
36. Roberts L.W., Warner T.D., Brody J.L., Roberts B., Lauriello J., Lyketsos C.: Patient and psychiatrist rating of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participation decisions. Am. J. Psychiatry 159: 573-584 (2002)
37. Rosenstein D.L., Miller F.G., Rubinow D.R.: A curriculum for teaching psychiatric research bioethics. Biol. Psychiatry 50: 802-808 (2001)
38. Temple R., Ellenberg S.S.: Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann. Intern. Med. 133: 455-463 (2000)
39. Wendler D.: Informed consent, exploitation and whether it is possible to conduct human subjects research without either one. Bioethics 1

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr